Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep146 | Calcium and Bone | ECE2021

Parathyroid elastography―elastography evaluation algorithm

Cotoi Laura , Andreea Borlea , Cepeha Cristina Mihaela , Nicusor Pop , Daniela-Georgiana Amzar , Dana Stoian

IntroductionPrimary hyperparathyroidism is a common disorder of the parathyroid glands and the third most frequent endocrinopathy, especially among elderly women. Secondary hyperparathyroidism is a common complication of chronic kidney disease, associated with high cardiovascular morbidity and mortality. In both primary and secondary hyperparathyroidism, the need to correctly identify the parathyroid glands is mandatory for a better outcome. Elastography...

ea0073aep578 | Reproductive and Developmental Endocrinology | ECE2021

Turner Syndrome–An unusual presentation of normal stature and incomplete puberty

Dias Daniela , Serra FIlipa , Neves Carolina , Real Mendes Leonor , Nogueira Filomena , Sapinho Inês

IntroductionTurner syndrome(TS) is characterized by complete/partial monosomy or by a structural defect in one of X chromosomes. Despite clinical hallmarks of short stature(SS) and gonadal dysgenesis(GD), phenotype is variable and related to underlying chromosomal pattern. Loss of the distal segment of the short arm of x-chromosome(Xp-), including haploinsufficiency of short stature homeobox-containing (SHOX) gene, is thought to be the main factor for gr...

ea0073aep735 | Thyroid | ECE2021

Block-replace therapy in the management of Graves’ disease

Ana-Maria Stancu , Gheorghiu Monica , Purice Mariana , Alexandrescu Daniela , Badiu Corin

IntroductionAnti-thyroid drugs (ATDs) are the first line treatment in Europe for hyperthyroidism due to Graves’ disease (GD). Adding levothyroxine to ATDs, so called block and replace therapy (BRT) is still controversial.AimTo follow up the outcomes after treating patients with Graves’ disease in a block and replace regimen.Patients & methodsA prospe...

ea0073aep868 | Late Breaking | ECE2021

Case report of complete androgen insensibility syndrome in an adult female

Daniela-Georgiana Amzar , Melania Balas , Ioana Golu , Mihaela Vlad , Dana Stoian , Cotoi Laura

IntroductionComplete androgen insensibility syndrome (CAIS) is an androgen receptor defect disorder associated with vaginal and uterine agenesis in women with a 46, XY karyotype. The syndrome affects sexual development before birth and during puberty. The major clinical issues surrounding this syndrome include timing of gonadectomy, hormone replacement, vaginal dilation, and attention to psychological issues.Case presentation<p...

ea0073ep149 | Pituitary and Neuroendocrinology | ECE2021

Apparently non secreting adenoma: a new challenge

Diana-Georgiana Lazar , Elena Oros Sabina , Dumitrascu Anda , Alexandrescu Daniela , Raluca Petria Andreea , Stoica Sergiu

IntroductionSilent corticotroph adenoma represent an uncommon subtype of nonfunctioning adenoma, immunoreactive for ACTH, without clinical or biochemical evidence of hypercortisolism and unclear pathogenesis. Usually, they present with local mass effect (visual deterioration being the most common) and endocrine dysfunctions. They carry a more aggressive behavior, particularly upon earlier recurrence.Case presentation<p class="a...

ea0092ps2-14-08 | Case Reports 1 | ETA2023

Thyrotoxic periodic paralysis: report of two cases

Triantafilo Schilling Yasson , Romero Quintanilla Katerine , Hernandez Munoz Hilda , Avila Osores Catalina , Avila Daniela

Introduction: Hypokalemic periodic paralysis (HPP) belongs to a group of inherited diseases called channelopathies, whose main manifestation include painless muscle paralysis. There are also acquired forms of HPP secondary to hyperthyroidism, called thyrotoxic periodic paralysis (TPP). It’s prevalence is markedly higher in men.Case Reports: Case 1. 34-year-old Venenzuelan man, without medical history. He consults in the emergency de...

ea0093oc53 | Oral communication 8: Interdisciplinary Endocrinology and Environment, Society and Governance | EYES2023

Metabolic and growth outcome of two-years growth hormone treatment in children born small for gestational age (SGA): A retrospective study

Ferrigno Rosario , Savanelli Maria Cristina , Cioffi Daniela , Pellino Valeria , Klain Antonella

Children born small for gestational age (SGA) not showing catch-up growth in early life may show decreased growth rate and adult height and worse metabolic profile compared to general population. In these patients, growth hormone (GH) treatment showed positive effects on growth rate and metabolic profile, with good tolerability. The aim of the study was to evaluate auxological and metabolic effects and safety of GH treatment in SGA children. Study included 34 SGA children (15 ...

ea0094p87 | Neuroendocrinology and Pituitary | SFEBES2023

Pituitary apoplexy: a retrospective study of 71 cases from a single center

Ghenoiu Sandra , Sandu Andreea , Dumitrascu Anda , Alexandrescu Daniela , Capatina Cristina , Poiana Catalina

Background and objective: The purpose of this study was to retrospectively analyse the clinical, imaging and hormonal features, as well as the therapeutic outcomes in a series of consecutive patients presenting with pituitary apoplexy (PA).Design: We retrospectively reviewed 71 case-records of patients with PA admitted during 2019 in a single tertiary endocrinology center.Results: ...

ea0036P82 | (1) | BSPED2014

An audit to assess the impact of increasing the borderline blood spot TSH cut-off on the detection of cases of congenital hypothyroidism (CHT) identified via newborn screening

Tetlow Lesley , Ehtisham Sarah , Hird Beverly , Manfredonia Claire , Nice Daniella , Scargill Jonathan , Steele Caroline

Background: The UK Newborn Screening Programme Centre Clinical Referral Standards and Guidelines for CHT (2013) define TSH cut-offs for screen positive (>20 mU/l) and borderline (>10 and <20 mU/l) results. In Manchester levels >8 and <20 mU/l are classified as borderline. This audit aims to assess whether adopting the national cut-off would result in babies with significant and permanent hypothyroid disease being missed.Patient popula...

ea0020oc2.2 | Diabetes &amp; Obesity | ECE2009

Thymocyte migration is impaired in NOD mice: combined role of extracellular matrix and chemokines

Mendes-da-Cruz Daniella , Bauer Moises , Smaniotto Salete , Keller Alexandre , Savino Wilson , Dardenne Mireille

The NOD (non-obese diabetic) mouse remains the best experimental model of type I diabetes. We have previously described several thymic dysfunctions in these animals, including the presence of giant perivascular spaces (PVS) with arrest of mature T cells (including Treg cells) and partial impairment on fibronectin/VLA-5-dependent NOD thymocyte migration. Herein, we further studied the role of extracellular matrix (ECM) ligands, alone or in combination with the chemokine CXCL12 ...